Lasker Professorship Awarded To Harvard Microbiologist

Max Essex, chairman of the department of cancer biology at Harvard University's School of Public Health and of the Harvard AIDS Institute, has been appointed the first Mary Lasker Professor of Health Sciences. The school established the Mary Woodard Lasker Professorship and Research Program in December in honor of the crusader and supporter of medical research who was a primary force in the establishment of the National Heart Institute, the National Institute of Mental Health, the National Ins

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Max Essex, chairman of the department of cancer biology at Harvard University's School of Public Health and of the Harvard AIDS Institute, has been appointed the first Mary Lasker Professor of Health Sciences.

The school established the Mary Woodard Lasker Professorship and Research Program in December in honor of the crusader and supporter of medical research who was a primary force in the establishment of the National Heart Institute, the National Institute of Mental Health, the National Institute of Neurological Diseases and Blindness, and the National Cancer Institute.

Essex, 50, has focused his work on the relationship of the immune system to cancer and infectious diseases. His research, which earned him an Albert Lasker Clinical Medical Research Award in 1986, provided the first link between viruses and suppression of immune defenses against disease. This research, including his work on HTLV (Science, 220:859-62, 1983), helped lead to the identification of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies